Study

Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study. – Cost Effective Supplements

Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/9840118


Conclusion of this study

Tauroursodeoxycholic acid improves the biochemical expression of chronic hepatitis. Long-term studies with clinically relevant end-points are warranted.


Supplements analyzed in this study

TUDCA

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Detox


Moderately Positive
TUDCA


Body systems related to this study


Digestive System
Scroll to top